Editor - Tamer Mahmoud Abd-Elfattah Mohamed | The University of | 18495

Atherosclerosis: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

10th World Heart Congress

Barcelona, Spain

33rd Annual Cardiologists Conference

Webinar, Webinar

World Cardiology Conference

Dublin, Ireland
Share This Page

Tamer Mahmoud Abd-Elfattah Mohamed

Tamer Mahmoud Abd-Elfattah Mohamed
Tamer Mohamed
Postdoctoral Research Associate
The University of Manchester
E-mail: [email protected]
The University of Manchester


Dr. Mohamed have a joint position between the J David Gladstone Research institutes at UCSF, USA and the Cardiovascular Research Institute at the University of Manchester, UK to carry out cutting edge research to try to treat heart failure using induced pluripotent stem cells derived cardiomyocytes cell therapy. In the past 12 years his research has focused on investigating novel mechanisms and therapies for cardiac hypertrophy and heart failure in animal models. As a pharmacist he had a special interest in the translation of his findings into human drug therapy for heart disease and he is currently using stem cell therapeutic approaches for heart failure treatment.

Research Interest

Investigating novel mechanisms and therapies for cardiac hypertrophy and heart failure.